Tag Archives: Microbiome-Based Therapeutics

Bugs and Drugs: The Promising Microbiome Frontier

BIO_Investor_Forum_RGB_Large

Tuesday at the 2016 BIO Investor Forum wrapped up with a panel discussion on the exciting potential of microbiome research, a relatively new but fast growing field in biopharama. Although still in an early phase, there has been growing excitement over the possibility of bringing new microbiome-derived drugs and therapies to the market.  With promising signs such as the $121M National Microbiome Initiative commitment from the White House, we can anticipate that this field will Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Session Recap: “Trust Your Gut” – Therapeutic Opportunities from the Microbiome

Kaylee_dna_115x76

Tuesday at the BIO CEO & Investor Conference kicked off with a Therapeutic Workshop titled, “Trust Your Gut” – Therapeutic Opportunities from the Microbiome. The panel was moderated by Mark Breidenbach, PhD, Equity Research Group, H.C. Wainwright & Co. The panelists were: Martin J. Blaser, MD, Muriel and George Singer Professor of Medicine, Professor of Microbiology, Director, Human Microbiome Program, New York University Langone Medical Center Karim Dabbagh, PhD, Chief Scientific Officer, Second Genome Michael Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Excerpts From Top Ten Current Science Trends Talk

biotech Primer

For the opening day of BIO 2014, BioTech Primer delivered a talk on the Top 10 Current Science Trends, Issues, & Advances.  Three of the technologies covered are highlighted below. Genome Editing: We often refer to a person’s genome – his complete set of genes – as a blueprint for life. But sometimes there are errors in this blueprint. Wouldn’t it be great if we could edit the blueprint and correct these errors? We might Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,